Header Logo

Connection

Jonathan Levin to Uganda

Back to Details
This is a "connection" page, showing publications Jonathan Levin has written about Uganda.
Jonathan Levin
Connection Strength
2,143
Uganda
  1. Combining national survey with facility-based HIV testing data to obtain more accurate estimate of HIV prevalence in districts in Uganda. BMC Public Health. 2020 Mar 23; 20(1):379.
    View in: PubMed
    Score: 0,166
  2. Difference in HIV prevalence by testing venue: results from population level survey in Uganda. AIDS Care. 2021 03; 33(3):273-284.
    View in: PubMed
    Score: 0,166
  3. Prevalence and risk factors of depression in childhood and adolescence as seen in four districts of North-Eastern Uganda. BMC Int Health Hum Rights. 2013 Apr 05; 13:19.
    View in: PubMed
    Score: 0,103
  4. Infection-exposure in infancy is associated with reduced allergy-related disease in later childhood in a Ugandan cohort. Elife. 2021 09 22; 10.
    View in: PubMed
    Score: 0,046
  5. Analysis of multivariate longitudinal immuno-epidemiological data using a pairwise joint modelling approach. BMC Immunol. 2021 09 17; 22(1):63.
    View in: PubMed
    Score: 0,046
  6. Effect of suicidality on clinical and behavioural outcomes in HIV positive adults in Uganda. PLoS One. 2021; 16(8):e0254830.
    View in: PubMed
    Score: 0,046
  7. Model-based small area estimation methods and precise district-level HIV prevalence estimates in Uganda. PLoS One. 2021; 16(8):e0253375.
    View in: PubMed
    Score: 0,046
  8. Major Depressive Disorder Among HIV Infected Youth in Uganda: Incidence, Persistence and Their Predictors. AIDS Behav. 2020 Sep; 24(9):2588-2596.
    View in: PubMed
    Score: 0,043
  9. Effect of Stopping Cotrimoxazole Preventive Therapy on Microbial Translocation and Inflammatory Markers Among Human Immunodeficiency Virus-Infected Ugandan Adults on Antiretroviral Therapy: The COSTOP Trial Immunology Substudy. J Infect Dis. 2020 07 06; 222(3):381-390.
    View in: PubMed
    Score: 0,042
  10. Maternal Latent Mycobacterium tuberculosis Does Not Affect the Infant Immune Response Following BCG at Birth: An Observational Longitudinal Study in Uganda. Front Immunol. 2020; 11:929.
    View in: PubMed
    Score: 0,042
  11. Clinical correlates and adverse outcomes of ADHD, disruptive behavior disorder and their co-occurrence among children and adolescents with HIV in Uganda. AIDS Care. 2020 11; 32(11):1429-1437.
    View in: PubMed
    Score: 0,042
  12. Rates, types and co-occurrence of emotional and behavioural disorders among perinatally HIV-infected youth in Uganda: the CHAKA study. Soc Psychiatry Psychiatr Epidemiol. 2019 Apr; 54(4):415-425.
    View in: PubMed
    Score: 0,039
  13. Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): A randomised placebo controlled trial. PLoS One. 2018; 13(12):e0206907.
    View in: PubMed
    Score: 0,038
  14. Major Depressive Disorder: Longitudinal Analysis of Impact on Clinical and Behavioral Outcomes in Uganda. J Acquir Immune Defic Syndr. 2018 06 01; 78(2):136-143.
    View in: PubMed
    Score: 0,037
  15. Virological failure on first-line antiretroviral therapy; associated factors and a pragmatic approach for switching to second line therapy-evidence from a prospective cohort study in rural South-Western Uganda, 2004-2011. Pan Afr Med J. 2018; 29:191.
    View in: PubMed
    Score: 0,036
  16. Association between major depressive disorder and pro-inflammatory cytokines and acute phase proteins among HIV-1 positive patients in Uganda. BMC Immunol. 2018 01 03; 19(1):1.
    View in: PubMed
    Score: 0,036
  17. Prevalence and correlates for ADHD and relation with social and academic functioning among children and adolescents with HIV/AIDS in Uganda. BMC Psychiatry. 2017 09 22; 17(1):336.
    View in: PubMed
    Score: 0,035
  18. The impact of antiretroviral therapy on symptom burden among HIV outpatients with low CD4 count in rural Uganda: nested longitudinal cohort study. BMC Palliat Care. 2017 Jul 13; 17(1):8.
    View in: PubMed
    Score: 0,034
  19. Incidence and Persistence of Major Depressive Disorder Among People Living with HIV in Uganda. AIDS Behav. 2017 Jun; 21(6):1641-1654.
    View in: PubMed
    Score: 0,034
  20. The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial. PLoS Negl Trop Dis. 2017 May; 11(5):e0005440.
    View in: PubMed
    Score: 0,034
  21. COHORT PROFILE: The Complications of Long-Term Antiretroviral Therapy study in Uganda (CoLTART), a prospective clinical cohort. AIDS Res Ther. 2017; 14:26.
    View in: PubMed
    Score: 0,034
  22. Uptake of hormonal contraceptives and correlates of uptake in a phase III clinical trial in rural South Western Uganda. Reprod Health. 2017 Mar 11; 14(1):36.
    View in: PubMed
    Score: 0,034
  23. Effect of antiretroviral therapy on malaria incidence in HIV-infected Ugandan adults. AIDS. 2017 02 20; 31(4):577-582.
    View in: PubMed
    Score: 0,034
  24. Major depressive disorder and suicidality in early HIV infection and its association with risk factors and negative outcomes as seen in semi-urban and rural Uganda. J Affect Disord. 2017 Apr 01; 212:117-127.
    View in: PubMed
    Score: 0,033
  25. Voluntary medical male circumcision for HIV prevention in fishing communities in Uganda: the influence of local beliefs and practice. Afr J AIDS Res. 2016 Sep; 15(3):211-8.
    View in: PubMed
    Score: 0,032
  26. Longitudinal effect of CD4 by cotrimoxazole use on malaria incidence among HIV-infected Ugandan adults on antiretroviral therapy: a randomized controlled study. Malar J. 2016 07 15; 15:361.
    View in: PubMed
    Score: 0,032
  27. Incidence of malaria by cotrimoxazole use in HIV-infected Ugandan adults on antiretroviral therapy: a randomised, placebo-controlled study. AIDS. 2016 Feb 20; 30(4):635-44.
    View in: PubMed
    Score: 0,031
  28. Factors associated with dropout in a long term observational cohort of fishing communities around lake Victoria, Uganda. BMC Res Notes. 2015 Dec 24; 8:815.
    View in: PubMed
    Score: 0,031
  29. Macrophage Inflammatory Protein-1 Beta and Interferon Gamma Responses in Ugandans with HIV-1 Acute/Early Infections. AIDS Res Hum Retroviruses. 2016 Mar; 32(3):237-46.
    View in: PubMed
    Score: 0,031
  30. High prevalence of hypertension and of risk factors for non-communicable diseases (NCDs): a population based cross-sectional survey of NCDS and HIV infection in Northwestern Tanzania and Southern Uganda. BMC Med. 2015 May 29; 13:126.
    View in: PubMed
    Score: 0,030
  31. Safety of discontinuing cotrimoxazole prophylaxis among HIV infected adults on anti-retroviral therapy in Uganda (COSTOP trial): Design. Contemp Clin Trials. 2015 Jul; 43:100-4.
    View in: PubMed
    Score: 0,030
  32. Hope: a new approach to understanding structural factors in HIV acquisition. Glob Public Health. 2015; 10(4):417-37.
    View in: PubMed
    Score: 0,029
  33. Development of Severe Anemia and Changes in Hemoglobin in a Cohort of HIV-Infected Ugandan Adults Receiving Zidovudine-, Stavudine-, and Tenofovir-Containing Antiretroviral Regimens. J Int Assoc Provid AIDS Care. 2015 Sep-Oct; 14(5):455-62.
    View in: PubMed
    Score: 0,029
  34. Impact of co-infections and BCG immunisation on immune responses among household contacts of tuberculosis patients in a Ugandan cohort. PLoS One. 2014; 9(11):e111517.
    View in: PubMed
    Score: 0,029
  35. Effect of seasonal variation on adult clinical laboratory parameters in Rwanda, Zambia, and Uganda: implications for HIV biomedical prevention trials. PLoS One. 2014; 9(8):e105089.
    View in: PubMed
    Score: 0,028
  36. Treatment outcomes of new tuberculosis patients hospitalized in Kampala, Uganda: a prospective cohort study. PLoS One. 2014; 9(3):e90614.
    View in: PubMed
    Score: 0,027
  37. Home-based versus clinic-based care for patients starting antiretroviral therapy with low CD4? cell counts: findings from a cluster-randomized trial. AIDS. 2014 Feb 20; 28(4):569-76.
    View in: PubMed
    Score: 0,027
  38. Comparison of methods for correction of mortality estimates for loss to follow-up after ART initiation: a case of the Infectious Diseases Institute, Uganda. PLoS One. 2013; 8(12):e83524.
    View in: PubMed
    Score: 0,027
  39. Dynamic logistic regression model and population attributable fraction to investigate the association between adherence, missed visits and mortality: a study of HIV-infected adults surviving the first year of ART. BMC Infect Dis. 2013 Aug 27; 13:395.
    View in: PubMed
    Score: 0,026
  40. Long-term consistent use of a vaginal microbicide gel among HIV-1 sero-discordant couples in a phase III clinical trial (MDP 301) in rural south-west Uganda. Trials. 2013 Feb 01; 14:33.
    View in: PubMed
    Score: 0,025
  41. Trends in child mortality: a prospective, population-based cohort study in a rural population in south-west Uganda. Paediatr Int Child Health. 2013 Feb; 33(1):23-31.
    View in: PubMed
    Score: 0,025
  42. HIV-1 subtype distribution trends and evidence of transmission clusters among incident cases in a rural clinical cohort in southwest Uganda, 2004-2010. AIDS Res Hum Retroviruses. 2013 Mar; 29(3):520-7.
    View in: PubMed
    Score: 0,025
  43. Mortality of HIV-infected and uninfected children in a longitudinal cohort in rural south-west Uganda during 8 years of follow-up. Trop Med Int Health. 2012 Jul; 17(7):836-43.
    View in: PubMed
    Score: 0,024
  44. Contribution of population factors to estimation of human immunodeficiency virus prevalence trends: a cohort study in rural Uganda, 1989-2007. Am J Epidemiol. 2011 Nov 15; 174(10):1175-82.
    View in: PubMed
    Score: 0,023
  45. Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial. Lancet Infect Dis. 2011 Dec; 11(12):933-41.
    View in: PubMed
    Score: 0,023
  46. Examining the components of population-level sexual behavior trends from 1993 to 2007 in an open ugandan cohort. Sex Transm Dis. 2011 Aug; 38(8):697-704.
    View in: PubMed
    Score: 0,023
  47. Prevalence and incidence of HIV in a rural community-based HIV vaccine preparedness cohort in Masaka, Uganda. PLoS One. 2011; 6(6):e20684.
    View in: PubMed
    Score: 0,023
  48. Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study. PLoS Med. 2011 Mar; 8(3):e1000427.
    View in: PubMed
    Score: 0,022
  49. Decreasing trends of bacteraemia among HIV-infected Ugandan adults: incidence, aetiology, clinical outcomes and effect of antiretroviral therapy in a semi-urban setting (2000-2008). Trop Med Int Health. 2011 Jun; 16(6):756-65.
    View in: PubMed
    Score: 0,022
  50. Adolescent suicidality as seen in rural northeastern Uganda: prevalence and risk factors. Crisis. 2011; 32(1):43-51.
    View in: PubMed
    Score: 0,022
  51. Barriers to starting ART and how they can be overcome: individual and operational factors associated with early and late start of treatment. Trop Med Int Health. 2010 Nov; 15(11):1347-56.
    View in: PubMed
    Score: 0,022
  52. Operational evaluation of a service for prevention of mother-to-child transmission of HIV in rural Uganda: barriers to uptake of single-dose nevirapine and the role of birth reporting. Trop Med Int Health. 2010 Oct; 15(10):1163-71.
    View in: PubMed
    Score: 0,022
  53. Comparison of home and clinic-based HIV testing among household members of persons taking antiretroviral therapy in Uganda: results from a randomized trial. J Acquir Immune Defic Syndr. 2010 Oct; 55(2):245-52.
    View in: PubMed
    Score: 0,022
  54. Symptom burden in HIV-infected adults at time of HIV diagnosis in rural Uganda. J Palliat Med. 2010 Apr; 13(4):375-80.
    View in: PubMed
    Score: 0,021
  55. Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. Lancet. 2009 Dec 19; 374(9707):2080-2089.
    View in: PubMed
    Score: 0,020
  56. Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health. 2009 Aug 11; 9:290.
    View in: PubMed
    Score: 0,020
  57. Willingness to participate in preventive HIV vaccine trials in a community-based cohort in south western Uganda. Trop Med Int Health. 2009 Feb; 14(2):196-203.
    View in: PubMed
    Score: 0,019
  58. Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of The AIDS Support Organization (TASO), Kampala, Uganda. BMC Health Serv Res. 2008 Nov 20; 8:241.
    View in: PubMed
    Score: 0,019
  59. Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda. Clin Infect Dis. 2008 Nov 01; 47(9):1126-34.
    View in: PubMed
    Score: 0,019
  60. Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe. J Acquir Immune Defic Syndr. 2008 Aug 01; 48(4):468-75.
    View in: PubMed
    Score: 0,019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.